Psychosocial Correlates of Clinicians' Prescription Drug Monitoring Program Utilization

Abstract

Introduction: The purpose of this study is to extend prior research on barriers to use of a prescription drug monitoring program by examining psychosocial correlates of intended use among physicians and pharmacists.

Methods: Overall, 1,904 California physicians and pharmacists responded to a statewide survey (24.1% response rate) from August 2016 to January 2017. Participants completed an online survey examining attitudes toward prescription drug misuse and abuse, prescribing practices, prescription drug monitoring program design and ease of use, professional obligations, and normative beliefs regarding prescription drug monitoring program use. Data were analyzed in 2017.

Results: Perceived prescription drug monitoring program usefulness and normative beliefs fully mediated the relationship between concern about prescription drug abuse and intentions to use the prescription drug monitoring program. Clinicians' sense of professional and moral obligation to use the prescription drug monitoring program was unrelated to intention to use the prescription drug monitoring program despite a positive relationship with concern about misuse and abuse. Compared with physicians, pharmacists reported greater concern about prescription drug misuse, greater professional and moral obligation to use prescription drug monitoring program, and greater rating of prescription drug monitoring program usefulness.

Conclusions: Interventions that target normative beliefs surrounding prescription drug monitoring program use and how to use prescription drug monitoring programs effectively are likely to be more effective than those that target professional obligations or moralize to the medical community.

Figure 1.

Final mediational model of the relationship between concern about prescription drug misuse and abuse and intention to use the California’s PDMP. Parameters represent unstandardized coefficients; presence of multiple path coefficients represents physicians and pharmacists, respectively. Covariance among exogenous variables and mediators were omitted for clarity. CS = controlled substances. Solid black lines indicate statistically significant paths and dashed black lines indicate non-significant paths among substantive pathways. Solid gray lines indicate paths for control variables. *** p <.001